These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11711290)

  • 1. Three-dimensional quantitative structure-activity relationship (3D-QSAR) of 3-aryloxazolidin-2-one antibacterials.
    Karki RG; Kulkarni VM
    Bioorg Med Chem; 2001 Dec; 9(12):3153-60. PubMed ID: 11711290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional quantitative structure-activity relationship (3D-QSAR) studies of tricyclic oxazolidinones as antibacterial agents.
    Gopalakrishnan B; Khandelwal A; Rajjak SA; Selvakumar N; Das J; Trehan S; Iqbal J; Kumar MS
    Bioorg Med Chem; 2003 Jun; 11(12):2569-74. PubMed ID: 12757724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure-activity relationship studies for prediction of antimicrobial activity of synthesized 2,4-hexadienoic acid derivatives.
    Narasimhan B; Judge V; Narang R; Ohlan R; Ohlan S
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5836-45. PubMed ID: 17869511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human protein tyrosine phosphatase 1B inhibitors: QSAR by genetic function approximation.
    Sachan N; Kadam SS; Kulkarni VM
    J Enzyme Inhib Med Chem; 2007 Jun; 22(3):267-76, 371-3. PubMed ID: 17674807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into structural requirements of antiamoebic flavonoids: 3D-QSAR and G-QSAR studies.
    Fatima S; Gupta P; Agarwal SM
    Chem Biol Drug Des; 2018 Oct; 92(4):1743-1749. PubMed ID: 29808545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.
    Sharma MC
    Interdiscip Sci; 2015 Sep; 7(3):221-32. PubMed ID: 26188391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional quantitative structure-activity relationship of 1,4-dihydropyridines as antitubercular agents.
    Kharkar PS; Desai B; Gaveria H; Varu B; Loriya R; Naliapara Y; Shah A; Kulkarni VM
    J Med Chem; 2002 Oct; 45(22):4858-67. PubMed ID: 12383011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modelling studies for the discovery of new substituted pyridines derivatives with angiotensin II AT1 receptor antagonists.
    Sharma MC
    Interdiscip Sci; 2014 Sep; 6(3):197-207. PubMed ID: 25205497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, antimicrobial, and QSAR studies of substituted benzamides.
    Kumar A; Narasimhan B; Kumar D
    Bioorg Med Chem; 2007 Jun; 15(12):4113-24. PubMed ID: 17428669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of polychlorinated phenols and evaluation of their toxicity, biodegradation and bioconcentration using three-dimensional quantitative structure-activity relationship models.
    Tong L; Guo L; Lv X; Li Y
    J Mol Graph Model; 2017 Jan; 71():1-12. PubMed ID: 27825025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSPR of 3-aryloxazolidin-2-one antibacterials.
    Katritzky AR; Fara DC; Karelson M
    Bioorg Med Chem; 2004 Jun; 12(11):3027-35. PubMed ID: 15142561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR, action mechanism and molecular design of flavone and isoflavone derivatives with cytotoxicity against HeLa.
    Liao SY; Chen JC; Qian L; Shen Y; Zheng KC
    Eur J Med Chem; 2008 Oct; 43(10):2159-70. PubMed ID: 18082913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D-QSAR of histone deacetylase inhibitors: hydroxamate analogues.
    Juvale DC; Kulkarni VV; Deokar HS; Wagh NK; Padhye SB; Kulkarni VM
    Org Biomol Chem; 2006 Aug; 4(15):2858-68. PubMed ID: 16855733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the dynamic quantitative structure-activity relationship method for modeling antibacterial activity of quinolone derivatives.
    Kamenska V; Mekenyan O; Sterev A; Nedjalkova Z
    Arzneimittelforschung; 1996 Apr; 46(4):423-8. PubMed ID: 8740092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: application of molecular field analysis.
    Nunthanavanit P; Anthony NG; Johnston BF; Mackay SP; Ungwitayatorn J
    Arch Pharm (Weinheim); 2008 Jun; 341(6):357-64. PubMed ID: 18442018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental and QSAR studies on antimicrobial activity of benzimidazole derivatives.
    Puratchikody A; Nagalakshmi G; Doble M
    Chem Pharm Bull (Tokyo); 2008 Mar; 56(3):273-81. PubMed ID: 18310935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.
    Nargotra A; Sharma S; Koul JL; Sangwan PL; Khan IA; Kumar A; Taneja SC; Koul S
    Eur J Med Chem; 2009 Oct; 44(10):4128-35. PubMed ID: 19523722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA models.
    Puntambekar DS; Giridhar R; Yadav MR
    Eur J Med Chem; 2008 Jan; 43(1):142-54. PubMed ID: 17448576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional structure-activity relationships and receptor mapping of N1-substituents of quinolone antibacterials.
    Ohta M; Koga H
    J Med Chem; 1991 Jan; 34(1):131-9. PubMed ID: 1992111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.